News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma
Sameer Rastogi/X
Jun 12, 2025, 15:42

Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma

Sameer Rastogi, Additional Professor at All India Institute of Medical Sciences, shared a post on X:

“Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. N=25, 76% previously exposed to pazopanib. 3-month progression-free rate: 56%. Median progression-free survival: 5 mths.”

Title: Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India

Authors: Sanal Fernandes, Sameer Rastogi, Kanu Priya Bhatia, Shamim A. Shamim, Adarsh Barwad, Rambha Pandey, Shivanand Gammanagatti, Ekta Dhamija

Read Full Article.

Low-dose Regorafenib

More posts featuring Sameer Rastogi on OncoDaily.

cancer OncoDaily Oncology regorafenib Sameer Rastogi
Special Coverage
Insight
Jul 3, 2025, 17:51
Maximilian Merz: How to Train Your Virtual Twin with 10 Million Euros
Blog
Jul 3, 2025, 17:40
Susanna Fletcher Greer: Striving to Support the Whole Person Behind the Science at the V Foundation
Opinion
Jul 3, 2025, 17:35
Andrew M Wardley: The Essential Role of a Cancer Plan in Shaping the Future of Cancer Care in the UK
Career
Jul 3, 2025, 17:22
George Yaghmour: Honored to Be Named The Leukemia and Lymphoma Society’s 2025 All-Star Top Fundraiser with 255,826 Dollars
Blog
Jul 3, 2025, 17:10
Oliver Bogler: Why I am Learning a New Way to Support Scientists
Blog
Jul 3, 2025, 17:01
Annalisa Saetta: Palliative Care Clerkship Increased Students’ Knowledge and Appreciation for a Holistic Approach
Blog
Jul 3, 2025, 16:46
Priscilla Chan: Accelerating Imaging Science so Researchers Can See Biology More Clearly
Insight
Jul 3, 2025, 16:42
Highlights From ESMO Gastrointestinal Cancers Congress 2025 by Arndt Vogel
Career
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
Career
Jul 3, 2025, 16:10
Bruno Vialli Has Been Appointed LATAM Procurement Manager for Media, Comms and Events at Sanofi
Insight
Jul 3, 2025, 16:01
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC
Insight
Jul 3, 2025, 15:48
ASMIRT shares updates on advocacy, research, and student support in Australia - ESTRO